Pancreatic Cancer | Epidemiology | Americas Data

Publish date: July 2017

Login to access report
  • The total number of incident cases of pancreatic cancer across the countries under study will increase by 38% from 13,871 to 19,163 in 10 years.
  • Among the countries considered in this analysis, the incidence of pancreatic cancer is highest in Canada at 13.4 per 100,000 per year.
  • 26/10/64% of all incident cases of pancreatic cancer across the countries under study are diagnosed with early stage/locally advanced/metastatic disease. 
  • The average age of all incident cases of pancreatic cancer across the countries under study is 70.

Table of contents

  • Americas Data
    • Introduction
      • Key Findings
      • Overview
        • Incidence of Pancreatic Cancer per 100,000 per Year Among People of All Ages in 2017 and 2027
        • Relative Sizes of the Factors Contributing to the Trend in Incident Cases of Pancreatic Cancer over the Next Ten Years
        • Analysis of the Incident Cases of Pancreatic Cancer in 2017 by Stage at Diagnosis
    • Epidemiology Data
    • Methods
      • Diagnosed Incident Cases
      • Stage Distribution of Pancreatic Cancer
      • Resection Status
      • Recurrent Incident Cases of Pancreatic Cancer
      • Diagnosed Prevalent Cases
      • Drug-Treatable Populations
    • Reference Materials
      • Literature Review
      • Risk/Protective Factors
      • Bibliography

Author(s): Nicole Zhang, MPH

Nicole Zhang is an Epidemiologist at Decision Resources Group. She focuses on the epidemiology of oncology and cardiovascular disorders. She holds an from Tufts Medical School where she specialized in epidemiology and biostatistics. She also holds a in Chemistry and Statistics from Mount Holyoke College. Prior to joining Decision Resources, she worked as a research analyst at Massachusetts General Hospital where she independently managed data from food information survey conducted in Chelsea, MA. She has also worked at Massachusetts Department of Public Health where she conducted secondary research in the fields of gestational diabetes.